Dynavax Technologies Corporation
World Rank (Jan-05-2024)
5,790
Market Cap (Jan-05-2024)
1.936 Billion USD
World Rank (Jul-30-2023)
6,079
Market Cap (Jul-30-2023)
1.826 Billion USD
World Rank (Dec-25-2022)
6,923
Market Cap (Dec-25-2022)
1.377 Billion USD
World Rank (Jan-07-2022)
7,127
Market Cap (Jan-07-2022)
1.62 Billion USD
Annual Revenue in USD
722 Million USD
Annual Net Income in USD
293 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Company Profile
Dynavax Technologies Corporation is a Fully Integrated Biopharmaceutical company focused on leveraging the power of the body's innate and adaptive immune responses through Toll like Receptor (TLR) stimulation. The headquarters is in USA.
Facts About Company
The company annual revenue is 46.55 million USD and 249 employees as on 2020.
Company Website